05.10.2022 • NewsNouryonADOBfertilizers

Nouryon Expands Portfolio with ADOB Fertilizers Buy

Nouryon has agreed to buy ADOB Fertilizers, a Polish-based supplier of chelated micronutrients, foliars and other specialty fertilizers. The move will expand Nouryon’s product portfolio and broaden its offerings for customers in the crop nutrition market.

© Shutterstock / camenic181
© Shutterstock / camenic181

Financial terms of the transaction, which is expected to close by the end of 2022, were not disclosed.

“With its strong focus on technology and innovation including biodegradable micronutrients, high-solubility specialty fertilizers and custom formulations, ADOB’s capabilities are an excellent complement to Nouryon’s existing capabilities in crop nutrition,” said Larry Ryan, the Dutch company’s executive vice president and president of performance formulations and the Americas.

Headquartered in Poznan, ADOB regards itself as the global leader of water-soluble fertilizers and micronutrients, and the biggest producer of foliar fertilizers in Poland. Its portfolio includes single, oligo and multi-nutrient fertilizers in liquid, crystalline and microgranular formulations.

The company runs two production plants, one in Poznan and one in Wroclaw-Zlotniki, and employs more than 400 people.

Adam Nawrocki, owner and CEO of ADOB, said the combination is a great opportunity to leverage a large global organization to advance to the next stage of global growth.

Author: Elaine Burridge, Freelance Journalist

Company

Logo:

Nouryon

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.